{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-039195","form_type":"8-K","ticker":"RNGE","cik":"0001438943","company_name":"RANGE IMPACT, INC.","filed_at":"2024-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.456721+00:00","generated_at":"2026-05-30T22:15:34.812181+00:00","sec_items":["1.01","2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Range Impact sells cannabinoid drug unit Graphium for warrants and cash","bullets":["Sold all Graphium common stock to Placer Biosciences, owned by former officers Dr. Zipp and Mr. McKilligan.","Consideration: warrants for 25% of Placer common stock (exercise price $0.01, expiring 2034), de minimis cash, 50% of equipment sale proceeds over 12 months.","Graphium held IP, permits, and lab equipment for early-stage cannabinoid therapeutics targeting Crohn’s disease and colitis.","Divestiture part of strategic shift to focus on acquiring, reclaiming, and repurposing mine land in Appalachia."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-039195","json":"https://secwatch.observer/filing/0001493152-24-039195.json","markdown":"https://secwatch.observer/filing/0001493152-24-039195.md","text":"https://secwatch.observer/filing/0001493152-24-039195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438943/000149315224039195/0001493152-24-039195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438943/000149315224039195/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T22:15:34.812181+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}